From science 2.0 to pharma 3.0 : semantic search and social media in the pharmaceutical industry and STM publishing / Hervé Basset, David Stuart and Denise Silber ; with contributions from François Boutin.

By:

Basset, Hervé

Contributor(s):

Series: Chandos social media series ; 7.2012Description: 1 online resource (xvi, 276 pages) : illustrationsContent type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9781780633756
1780633750

Subject(s):

Genre/Form:

Electronic books.

Additional physical formats: Print version:: From Science 2.0 To Pharma 3.0 : Semantic Search And Social Media In The Pharmaceutical Industry And Stm Publishing.LOC classification:

HM742 .B37 2012

Online resources:

Contents:

Cover; From Science 2.0 to Pharma 3.0: Semantic search and social media in the pharmaceutical industry and STM publishing; Copyright; Contents; List of figures; List of abbreviations; Acknowledgements; Note; About the authors; Notes; Introduction; Notes; Part 1 From Science 2.0 (2000-2010) ... ; 1The Web 2.0 revolution and the promise of Science 2.0; The web as a platform: web services, the cloud and the app; Harnessing collective intelligence; Data as the 'next Intel Inside'; Notes; 2The state of Science 2.0; A reluctance to change; Scepticism about the promise of Science 2.0.

The lack of a supportive environmentConclusion; Note; Part 2 ... and Pharma 2.0 ... ; 3Health 2.0 and beyond; 2.0 becomes social media; Big promises: is there a pot of gold?; Leading Health 2.0 and social media sites and applications; Notes; 4The digital pharma industry; The pharma industry adopts ... ; The pharma industry watches ... ; The pharma industry remains cautious: the dark face of SoMe; Notes; Part 3 ... to Pharma 3.0 (2010- ); 5The semantic search in life sciences; Semantic? What's this?; What do researchers expect?; A survey of biomedical semantic interfaces; The future will be semantic.

The semantic for pharmasNotes; 6Enterprise 2.0 and Web 3.0; Enterprise 2.0; MS SharePoint 2010; And the next revolutions are?; Conclusion; Notes; 7The next 3.0; Science 3.0; Pharma 3.0; Big STM 3.0; Notes; Conclusion; Science 2.0; Health 2.0, digital marketing and Pharma 3.0; Big STM and big pharma; Web 3.0; Notes; References; Index.

Summary: Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered. This title is divided into three parts. The first part considers the Web 2.0 revolution, and the promise of its impact on science communication and the state of Science 2.0. The second part looks at impact on Pharma and Health, including attempts to utilise digital in Pharma. The last part looks at the promising disruptive technologies of Web 3.0, including semantic search in biomedicine and enterprise platforms. The book concludes by looking forward to developments of '3.0' in Pharma and STM publishing.

Item type:

eBooks

Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 8 )

No physical items for this record

Includes bibliographical references and index.

Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered. This title is divided into three parts. The first part considers the Web 2.0 revolution, and the promise of its impact on science communication and the state of Science 2.0. The second part looks at impact on Pharma and Health, including attempts to utilise digital in Pharma. The last part looks at the promising disruptive technologies of Web 3.0, including semantic search in biomedicine and enterprise platforms. The book concludes by looking forward to developments of '3.0' in Pharma and STM publishing.

Print version record.

Elsevier ScienceDirect All Books

Safari Books Online Safari Tech Books Online